Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • bastianwur
    Member
    • Feb 2014
    • 98

    #1

    What to do if you only have a single RNAseq condition?

    The setup is for sure more complicated, we sequenced more than only a single condition, but it boils down that I need to somehow do something with RNAseq reads for only a single condition.

    Background:
    The guys in the lab did 3 conditions: Growth of bacterium A in a chemically defined medium (duplo), growth of A and B in the same medium (duplo) and growth of A and C in the same medium (duplo).
    B and C cannot be grown in the same medium (or in general on their own), probably due to auxotrophies (but basically nobody knows).

    There are some hypothesises here. We expect that B produces a vitamin for A, experimental conditions see a production of a compound which will need this vitamin, and the RNAseq in bacterium A indicates that this works.
    Now we also hypothesise that A gives amino acids and some vitamins to B (based on a pathway tools model).
    We'll for sure have a look at A, to see if we see some change in expression there in the relevant pathways.

    But what do I do with the RNAseq data of organism B and C?
    There's only one condition.
    They cannot be grown on their own
    There's no data whatsoever available from another lab.

    I can have a look at the highly expressed genes, but as we all know, this doesn't have to mean very much.

    I'd be happy if anyone had an idea what I could do with it.
    I don't think I necessarily need to look at it for a nice story, but I'd like to do a full analysis here.

    Thanks

Latest Articles

Collapse

  • SEQadmin2
    Beyond CRISPR/Cas9: Understand, Choose, and Use the Right Genome Editing Tool
    by SEQadmin2



    CRISPR/Cas9 sparked the gene editing revolution for both research and therapeutics.1 But this system still showed severe issues that limited its applications. The most prominent were the heavy reliance on PAM sequences, delivery limitations, double-stranded breaks that prompt unintended edits and cell death, and editing inefficiency (both in targeting and in knock-in reliability).

    Despite this, “CRISPR helped turn genome editing from a specialized technique into
    ...
    07-31-2026, 11:01 AM
  • SEQadmin2
    Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
    by SEQadmin2


    Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

    The systematic characterization of the human proteome has
    ...
    07-20-2026, 11:48 AM
  • SEQadmin2
    Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
    by SEQadmin2



    Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
    ...
    07-09-2026, 11:10 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by SEQadmin2, 08-03-2026, 10:13 AM
0 responses
15 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 07-31-2026, 02:55 AM
0 responses
32 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 07-24-2026, 12:17 PM
0 responses
23 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 07-23-2026, 11:41 AM
0 responses
21 views
0 reactions
Last Post SEQadmin2  
Working...